Experts suggest that an experimental cancer drug developed by Pfizer could provide a potential treatment in slowing down the spread of advanced breast cancer. The drug, called palbociclib, when administered with another anti-cancer drug already on the market, letrozole, stopped cancer progression for a median of 20 months. That was double the amount of time seen in a control group of patients who did not receive palbociclib. However, those ...Tuesday 8 April 2014
Pfizer Drug Shows Promise in Slowing Down Breast Cancer Progression
Experts suggest that an experimental cancer drug developed by Pfizer could provide a potential treatment in slowing down the spread of advanced breast cancer. The drug, called palbociclib, when administered with another anti-cancer drug already on the market, letrozole, stopped cancer progression for a median of 20 months. That was double the amount of time seen in a control group of patients who did not receive palbociclib. However, those ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment